| answer text |
<p>The Department invests £1 billion per year in health research through the National
Institute for Health Research (NIHR). The NIHR does not allocate funding for specific
disease areas. The following table shows the NIHR’s Programme funding for pancreatic
cancer in each of the last three years.</p><table><tbody><tr><td><p>Year</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>Total</p></td></tr><tr><td><p>NIHR
Research Programmes total</p></td><td><p>£350,870</p></td><td><p>£411,444</p></td><td><p>£534,170</p></td><td><p>£1,296,484</p></td></tr></tbody></table><p>
</p><p>In addition, the NIHR Clinical Research Network supported 62 studies over the
last three years.</p><p>Several factors are considered when deciding which ‘Be Clear
on Cancer’ (BCOC) campaigns to develop and run, with one of the main criteria being
the scope to save lives through earlier diagnosis. This can only be effective through
broad awareness campaigns if the cancer has a high enough incidence to be able to
impact upon through marketing campaigns, as well as a clear early sign or symptom
that the public can act upon should it arise.</p><p>In 2017, Public Health England
(PHE) ran a pilot campaign in the East and West Midlands which focussed on a range
of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative
of several cancers, including pancreatic cancer. In 2017, PHE also ran a pilot campaign
in the East and West Midlands which focussed on a range of abdominal symptoms, such
as diarrhoea, bloating and discomfort that can be indicative of several cancers, including
pancreatic cancer. Further information on the pilot is available at the following
link:</p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot"
target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot</a></p><p>PHE
is currently undertaking new data analysis and research to determine the future direction
of BCOC activity.</p><p>Over the next three years every patient with cancer will receive
a Personalised Care and Support Plan based on holistic needs assessment, end of treatment
summaries and health and wellbeing information and support. All patients, including
those with secondary cancers, will have access to the right expertise and support,
including a Clinical Nurse Specialist or other support worker.</p><p> </p><p> </p><p>
</p><p> </p><p> </p>
|
|
